Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.


Journal

Journal of anesthesia
ISSN: 1438-8359
Titre abrégé: J Anesth
Pays: Japan
ID NLM: 8905667

Informations de publication

Date de publication:
10 2021
Historique:
received: 03 05 2021
accepted: 06 06 2021
pubmed: 26 6 2021
medline: 29 9 2021
entrez: 25 6 2021
Statut: ppublish

Résumé

In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and dose of these two sedatives were compared. Mixed sedation days were excluded. Patients' age (median [interquartile range]) was 64 (60-68) years. They were invasively ventilated for 36 [21-50] days. End-tidal isoflurane concentrations were high (0.96 ± 0.41 Vol %); multiple linear regression yielded the ratio (isoflurane infusion rate)/(minute ventilation) as the single best predictor. Infusion rates were decreased under ECMO (3.5 ± 1.4 versus 7.1 ± 3.2 ml∙h Isoflurane provided sufficient sedation with less NMBAs, less polypharmacy and lower opioid doses compared to propofol. High doses of both drugs were needed in severely ill COVID-19 patients.

Identifiants

pubmed: 34169362
doi: 10.1007/s00540-021-02960-6
pii: 10.1007/s00540-021-02960-6
pmc: PMC8225486
doi:

Substances chimiques

Hypnotics and Sedatives 0
Isoflurane CYS9AKD70P
Propofol YI7VU623SF

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

625-632

Informations de copyright

© 2021. The Author(s).

Références

Eur J Anaesthesiol. 2013 Aug;30(8):455-63
pubmed: 23545542
Med Intensiva. 2013 Nov;37(8):519-74
pubmed: 23773859
Ger Med Sci. 2015 Nov 12;13:Doc19
pubmed: 26609286
J Crit Care. 2021 Jun;63:104-105
pubmed: 33019992
Eur J Anaesthesiol. 2008 Feb;25(2):152-7
pubmed: 17655810
Am J Emerg Med. 2021 Apr;42:250
pubmed: 32732086
EBioMedicine. 2020 May;55:102770
pubmed: 32344199
Crit Care Med. 2004 Nov;32(11):2241-6
pubmed: 15640636
Crit Care. 2009;13(5):R169
pubmed: 19874582
Korean J Anesthesiol. 2012 Nov;63(5):391-401
pubmed: 23198031
Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):523-38
pubmed: 16013698
Respir Care. 2008 Oct;53(10):1295-303
pubmed: 18811990
Intensive Care Med. 2020 Aug;46(8):1563-1566
pubmed: 32588067
Respir Care. 2018 Apr;63(4):441-447
pubmed: 29233852
Br J Anaesth. 2020 Aug;125(2):118-121
pubmed: 32416995
J Am Med Dir Assoc. 2014;15(11):850.e11-5
pubmed: 25405712
J Intensive Care Med. 2021 Feb;36(2):157-174
pubmed: 32844730
Anesth Analg. 2020 Jul;131(1):e40-e41
pubmed: 32392023
Br J Anaesth. 2003 Aug;91(2):170-4
pubmed: 12878613
J Intensive Care Soc. 2015 Aug;16(3):234-238
pubmed: 28979416
Ann Thorac Surg. 2017 Jul;104(1):e85
pubmed: 28633272
J Clin Anesth. 1995 Nov;7(7):558-63
pubmed: 8652166
Intensive Care Med. 2020 Jun;46(6):1099-1102
pubmed: 32291463
Clin Exp Immunol. 2012 Apr;168(1):125-34
pubmed: 22385247
Br J Anaesth. 2020 Dec;125(6):912-925
pubmed: 32988604
Anesth Analg. 2017 Apr;124(4):1190-1199
pubmed: 27828800
Anesthesiology. 1965 Nov-Dec;26(6):756-63
pubmed: 5844267
Int J Crit Illn Inj Sci. 2011 Jan;1(1):84-6
pubmed: 22096779
Anaesth Crit Care Pain Med. 2020 Jun;39(3):341-343
pubmed: 32360979
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Lancet Diabetes Endocrinol. 2020 Jul;8(7):562-564
pubmed: 32437642
Crit Care. 2020 Jun 8;24(1):315
pubmed: 32513237
Br J Anaesth. 2020 Nov;125(5):e441-e442
pubmed: 32912604
Br J Anaesth. 2020 Dec;125(6):e475-e476
pubmed: 32928516
Ann Intensive Care. 2019 Mar 25;9(1):41
pubmed: 30911854
Expert Rev Med Devices. 2021 Feb;18(2):189-195
pubmed: 33322972
Br J Anaesth. 2019 Apr;122(4):448-459
pubmed: 30857601
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Pharmacology. 2012;90(5-6):342-7
pubmed: 23095677
J Clin Monit Comput. 2018 Aug;32(4):639-646
pubmed: 29700664
Anesthesiology. 2009 Dec;111(6):1238-48
pubmed: 19934867
Anesth Analg. 2017 Oct;125(4):1235-1239
pubmed: 28301417
Am J Respir Crit Care Med. 2017 Mar 15;195(6):792-800
pubmed: 27611637
Lancet Respir Med. 2021 Nov;9(11):1231-1240
pubmed: 34454654
Eur J Anaesthesiol. 2016 Jan;33(1):6-13
pubmed: 25793760

Auteurs

Azzeddine Kermad (A)

Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany. azzeddine.kermad@uks.eu.

Jacques Speltz (J)

Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany.

Guy Danziger (G)

Department of Internal Medicine V-Pulmonology, Allergology and Intensive Care Medicine, Saarland University Hospital Medical Center, Homburg, Saarland, Germany.

Thilo Mertke (T)

Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany.

Robert Bals (R)

Department of Internal Medicine V-Pulmonology, Allergology and Intensive Care Medicine, Saarland University Hospital Medical Center, Homburg, Saarland, Germany.

Thomas Volk (T)

Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany.

Philipp M Lepper (PM)

Department of Internal Medicine V-Pulmonology, Allergology and Intensive Care Medicine, Saarland University Hospital Medical Center, Homburg, Saarland, Germany.

Andreas Meiser (A)

Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH